Fundraising Fox

Ribon Therapeutics

Lexington, US · Founded 2015 · Delaware corporation · 4 known investors

Biotech

Founders & leadership

CW
Cameron WheelerDirector
JR
Jonathan RootDirector
LL
Laurence LaskyDirector
VM
Victoria M. RichonExecutive Officer, Director

Investors · 4

Avego BioScience CapitalAlpharetta
OUP (Osage University Partners)Bala Cynwyd · $1M – $20M
Peregrine VenturesOr Yehuda · $500K – $3M
The Column GroupreportedSan Francisco · $30Mvia Jeff Goater · board

Reported raises · per SEC filings

Form D private placements
▶$25MraisedDec 2022 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Laura BrassDirector
  • Emma ReeveDirector
  • Jonathan RootDirector
  • Eyal LifschitzDirector
  • Paul BrannellyExecutive Officer
  • James AudiaDirector
  • Jodie MorrisonDirector
  • Cameron WheelerDirector
  • Prakash RamanExecutive Officer, Director
  • Jeff GoaterDirector
  • Gary SuttonExecutive Officer
Offering amount
$25M
Amount sold
$25M
First sale
Dec 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$25.2MraisedJun 2021 · 16 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Marian NakadaDirector
  • Svennilson PeterDirector
  • Edward StewartExecutive Officer
  • Cameron WheelerDirector
  • James AudiaDirector
  • Victoria M. RichonExecutive Officer, Director
  • Emma ReeveDirector
  • Jodie MorrisonDirector
  • Laura BrassDirector
  • Jonathan RootDirector
Offering amount
$60.2M
Amount sold
$25.2M
First sale
Jun 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$25.4MraisedJan 2019 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Anja KoenigDirector
  • James AudiaDirector
  • Marian NakadaDirector
  • Svennilson PeterDirector
  • Victoria M. RichonExecutive Officer, Director
  • Jonathan RootDirector
  • Cameron WheelerDirector
  • David CordoExecutive Officer
Offering amount
$65M
Amount sold
$25.4M
First sale
Dec 2018
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$20MraisedOct 2017 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Victoria M. RichonExecutive Officer, Director
  • David CordoExecutive Officer
  • Cameron WheelerDirector
  • Jonathan RootDirector
  • Laurence LaskyDirector
Offering amount
$20M
Amount sold
$20M
First sale
Oct 2017
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$23.5MraisedNov 2016 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Cameron WheelerDirector
  • Jonathan RootDirector
  • Laurence LaskyDirector
  • Victoria M. RichonExecutive Officer, Director
Offering amount
$23.5M
Amount sold
$23.5M
First sale
Nov 2015
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.